Sam Altman is co-founding Merge Labs, a brain-computer interface startup that will use ultrasound and gene therapy for less invasive neural interfaces. The company represents a direct competitor to Elon Musk’s Neuralink with a fundamentally different technical approach.
Retinal Implant Offers New Hope for Macular Degeneration Patients In a groundbreaking medical advancement, researchers have successfully restored reading ability…
Unlocking the Brain’s Anxiety Control Center Groundbreaking research published in Nature Neuroscience has revealed a specialized population of leptin receptor-expressing…
Unraveling the Genetic Mysteries of Neonatal Diabetes In a significant medical advancement, researchers have pinpointed a previously unknown genetic driver…
